![HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcddis.2017.237/MediaObjects/41419_2017_Article_BFcddis2017237_Fig1_HTML.jpg)
HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease
![Mechanism of action of integrase inhibitors. Based on the findings of... | Download Scientific Diagram Mechanism of action of integrase inhibitors. Based on the findings of... | Download Scientific Diagram](https://www.researchgate.net/profile/Marianne-Harris-2/publication/46108205/figure/fig1/AS:669323433615390@1536590550793/Mechanism-of-action-of-integrase-inhibitors-Based-on-the-findings-of-Hazuda-et-al-2000.png)
Mechanism of action of integrase inhibitors. Based on the findings of... | Download Scientific Diagram
![Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum](https://cdn.hiv.uw.edu/doc/942-1/mechanism-action-attachment-inhibitors.jpg)
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
![Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-783X-14-S3-5/MediaObjects/40001_2009_Article_506_Fig2_HTML.jpg)
Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text
![Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised ... Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/44cf8370-21b7-4986-bb1f-b20734f644f2/gr1_lrg.gif)
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised ...
![HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcddis.2017.237/MediaObjects/41419_2017_Article_BFcddis2017237_Fig9_HTML.jpg)
HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination | Cell Death & Disease
![Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text Raltegravir: molecular basis of its mechanism of action | European Journal of Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2047-783X-14-S3-5/MediaObjects/40001_2009_Article_506_Fig1_HTML.jpg)